|
TMEM194A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.963300E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.858430E-02 |
| Normal-vs-Stage2 |
5.751700E-04 |
| Normal-vs-Stage3 |
3.214700E-04 |
| Normal-vs-Stage4 |
3.997600E-03 |
| Stage1-vs-Stage2 |
4.967700E-02 |
| Stage1-vs-Stage3 |
6.751600E-02 |
| Stage1-vs-Stage4 |
2.379400E-01 |
| Stage2-vs-Stage3 |
5.686400E-01 |
| Stage2-vs-Stage4 |
4.711600E-01 |
| Stage3-vs-Stage4 |
7.919600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.137770E-02 |
| Normal-vs-AfricanAmerican |
7.025700E-02 |
| Normal-vs-Asian |
4.227800E-02 |
| Caucasian-vs-AfricanAmerican |
9.318800E-01 |
| Caucasian-vs-Asian |
7.602800E-01 |
| AfricanAmerican-vs-Asian |
7.826400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.243800E-04 |
| Normal-vs-Female |
1.065750E-02 |
| Male-vs-Female |
2.914000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.234000E-02 |
| Normal-vs-Age(41-60Yrs) |
4.303800E-03 |
| Normal-vs-Age(61-80Yrs) |
3.54430000000239E-05 |
| Normal-vs-Age(81-100Yrs) |
9.417300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.710430E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.561900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.040190E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.036020E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.042200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.920600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.802840E-01 |
| Classical-VS-Follicular |
9.920500E-02 |
| Classical-VS-Other |
3.316200E-01 |
| Classical-VS-Normal |
2.078500E-02 |
| Tall-VS-Follicular |
8.509400E-01 |
| Tall-VS-Other |
7.567800E-01 |
| Tall-VS-Normal |
6.179400E-03 |
| Follicular-VS-Other |
9.110200E-01 |
| Follicular-VS-Normal |
3.742100E-03 |
| Other-VS-Normal |
7.554100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.827300E-04 |
| Normal-vs-N1 |
8.084800E-03 |
| N0-vs-N1 |
5.646000E-01 |
|
|
